Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.6000 (1.4%) ($7.3500 - $7.6100) on Mon. Apr. 24, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.98% (three month average) | RSI | 33 | Latest Price | $7.6000(1.4%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1.3% a day on average for past five trading days. | Weekly Trend | BCRX declines -6.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) ARKG(31%) CEMB(24%) XLRE(23%) BND(21%) EWI(21%) | Factors Impacting BCRX price | BCRX will decline at least -1.49% in a week (0% probabilities). VIXM(-19%) VXX(-17%) UUP(-12%) TLT(-12%) VCIT(-9%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.49% (StdDev 2.98%) | Hourly BBV | 2.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-2.25(-129.61%) | Resistance Level | $8.16 | 5 Day Moving Average | $7.49(1.47%) | 10 Day Moving Average | $7.87(-3.43%) | 20 Day Moving Average | $8.16(-6.86%) | To recent high | -31.6% | To recent low | 2.8% | Market Cap | $1.341b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |